Garrett Winslow
CIK 1803773 · General Counsel · last filed 2026-03-25
Garrett Winslow is a General Counsel who has filed 13 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for DMRA, was dated Mar 25, 2026. Across all open-market trades the lifetime net is +$4.8K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
13
$4.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMRA | General Counsel | — | $20.78 | — | $0 | 1 | 2026-03-25 |
| Damora Therapeutics, Inc. (GLTO) Delisted | General Counsel | 2,109 | $28.69 | $60.5K | $5.6K | 10 | 2026-01-06 |
| F-star Therapeutics, Inc. (SBPH) Delisted | General Counsel and Secretary | 18,750 | — | — | -$833 | 2 | 2020-11-23 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-25 | DMRA | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +425 | -$5.5K | EDGAR |
| 2025-07-08 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +420 | -$881 | EDGAR |
| 2025-01-07 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +849 | -$2.6K | EDGAR |
| 2024-10-11 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-05 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-06 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | Damora Therapeutics, Inc. (GLTO) Delisted | Buy (P) | +2,000 | $5.0K | EDGAR |
| 2021-06-23 | Damora Therapeutics, Inc. (GLTO) Delisted | Buy (P) | +2,000 | $9.6K | EDGAR |